P+P and Araoz & Rueda Abogados advise Dermapharm on takeover of EUROMED
Dermapharm Holding SE has aquired 100% of the shares in the Spanish phytopharmaceuticals supplier EUROMED S.A., Barcelona. The seller was the U.S. investor The Riverside Company.
Dermapharm Holding SE is headquartered in Grünwald and concentrates on the manufacture and marketing of high-quality dermatological and pharmaceuticals for allergic conditions.
Euromed was founded in 1971 in Madaus (today Meda) and manufactures standardized herbal extracts with natural active ingredients for the pharmaceutical and cosmetic industries. The company has two production facilities in Barcelona and in the Murcia province. They produce approximately 5000 tons of biomass per year. In 2019, they expect to generate turnover of approximately EUR 70 million.
P+P Pöllath + Partners and the Spanish law firm Araoz & Rueda Abogados advised Dermapharm Holding SE with the following team:
P+P Pöllath + Partners:
- Dr. Matthias Bruse (partner, lead, M&A, Munich)
- Daniel Wiedmann (associated partner, antitrust law, Frankfurt)
- Philipp Kopp (senior associate, M&A, Munich)
- Thies Jacob (associate, M&A, Munich)
Araoz & Rueda Abogados:
- Alejandro Fernández de Araoz (partner, lead, M&A, Madrid)
- Vicente Paramio (senior associate, M&A, Madrid
